barclays will ge coming out with trading update on 07.05.2009 It is expected to report profits higher than market expectations.

A good Buy Medium to Long term

hyleo - am i not correct in thinking that you regularly shout SELL, SELL, SELL from the rooftops but lack the balls ever to stick money in your gaping orifice?

Are u saying BARC a buy then?
I think you are the most vulgar and uncivilized person on this forum.
Certainly tells a story of your upbringing.

no - i'm neutral on banks ..... and just because you don't like what i write does not make me uncivilised (please learn to spell in the english manner!) ..... btw, i assume that what i wrote above was absolutely true, for assuredly you do not dispute that i reckon you're all mouth

It does not concern you whether I buy or sell?
And you are forever sitting on fences with your neutral opinions.

not at all ..... i have a trading portfolio which is currently 16 strong; sometimes it's a bit bigger and sometimes a little less and i keep an watch on about 40/50 stocks/indices

however, and i'm more than happy to repeat, you're all mouth and trousers

1st qtr interim management statement on 24th april should be interesting.

Interim Management Statement

- Adjusted profit before tax was down 25% (£609m) to £1,786m. Excluding costs to achieve Transform of £514m and non-recurrence of a £235m gain in Q1 12 in relation to hedges of employee share awards would have resulted in an increase in adjusted profit before tax of 6%

- Statutory profit before tax improved to £1,535m (Q1 12: £525m loss), reflecting a reduced own credit charge of £251m (Q1 12: £2,620m)

- Adjusted return on average shareholders' equity decreased to 7.6% (Q1 12: 12.4%) reflecting the costs to achieve Transform. Statutory return on average shareholders' equity improved to 6.5% (Q1 12: negative 4.5%)

- Adjusted income decreased 5% to £7,734m, principally due to non-recurrence of the gain in relation to hedges of employee share awards. Investment Bank income was up 1% at £3,463m (Q1 12: £3,436m) and was up 34% on Q4 12

- Credit impairment charges decreased 10% to £706m, with an annualised loan loss rate of 56bps (Q1 12: 63bps), principally reflecting improvements in the Investment Bank and Corporate Banking

- Adjusted operating expenses were up 7% at £5,296m. This reflected £514m of costs to achieve Transform, restructuring principally in Europe RBB and the Investment Bank, partially offset by a £183m reduction in other operating expenses. Adjusted cost to income ratio was 68% (Q1 12: 61%) with the increase attributable to costs to achieve Transform

- Risk weighted assets increased 3% to £398bn primarily driven by foreign currency movements

- Core Tier 1 ratio strengthened to 11.0% (2012: 10.8%), principally reflecting capital generated from earnings and the exercise of warrants

- Net asset value per share of 405p (2012: 414p) and net tangible asset value per share of 344p (2012: 349p) reflecting an increase in shares issued, including the exercise of warrants

- We provided an estimated £20bn of Funding for Lending Scheme (FLS) eligible gross new lending to UK households and businesses in Q1 13. Barclays was the leading provider of loans to UK households and businesses under the national loan guarantee scheme and the FLS through Q4 12

Bank of America Merrill Lynch Buy 297.93 430.00 430.00 Retains

Canaccord Genuity Hold 297.93 280.00 280.00 Reiterates

Investec Buy 297.93 - 345.00 Reiterates

Credit Suisse Neutral 297.93 290.00 290.00 Reiterates

Canaccord Genuity Hold 297.93 280.00 280.00 Reiterates

Investec Buy 297.93 345.00 - Reiterates

Credit Suisse Neutral 297.93 290.00 290.00 Reiterates

Deutsche Bank Buy 297.93 380.00 380.00 Retains

Citigroup Buy 289.75 450.00 450.00 Reiterates

Numis Buy 289.75 400.00 400.00 Reiterates

Barclays wins dismissal of U.S. shareholder lawsuit over Libor

Tue May 14, 2013 1:41am BST

(Reuters) - Barclays Plc, the first bank to settle with authorities over alleged manipulation of the Libor interest rate, on Monday won the dismissal of a U.S. lawsuit by shareholders who claimed they lost money because of the British bank's activity.

U.S. District Judge Shira Scheindlin in Manhattan said investors who owned Barclays' American depositary shares did not show that Barclays and other defendants, including former Chief Executives John Varley and Bob Diamond, misled them about Libor or took too long to reveal potential liabilities.

Barclays falls on placement as Europe opens flat

(Reuters) - UK lender Barclays was among the top fallers after a share placement as European equities were expected to be volatile ahead of jobs data in the U.S., a strong reading of which could drive markets lower.

Barclays fell 1.7 percent with traders citing market speculation that Nomura had placed 84.5 million Barclays shares on the market at 308.5 pence. Barclays' shares closed at 316.30 pence on Wednesday.

By 0706 GMT on Thursday, the FTSEurofirst 300 was up 0.5 of a point at 1,193.27, having fallen nearly 10 percent in the last nine days on concerns the U.S. Federal Reserve could start tapering its stimulus measures earlier than expected in the wake of recent strong economic data.

.

RNS suggests Sumitomo Mitsui Bank has sold BARC shares worth $400m

Toying with the 200ma - downgraded by S&P to A from A+.

results due 30 july, xd 7 aug.

Barclays fined $435m in US over energy market-rigging

US regulators have fined Barclays $435m (£287m) for manipulating energy markets in California and other states from November 2006 to December 2008.

Barclays and four of its traders must also pay $34.9m to the low-income home energy assistance programs of Arizona, California, Oregon and Washington.

They have 30 days to pay the fines imposed by the Federal Energy Regulatory Commission.

Barclays said it intended to "vigorously defend this matter".

Long on the spreads @ 316.4 target 339.0 results coming up then ex-divi.

sp faltering ahead of results next week.

Stopped out @ 321.4 + 5.0

Interims tomorrow.

Barclays says will give update on capital plans Tuesday

Espirito Santo Execution Noble Buy 312.33 418.00 418.00 Reiterates

Investec Buy 312.33 345.00 345.00 Reiterates

Bank of America Merrill Lynch Buy 312.33 370.00 370.00 Retains

JP Morgan Cazenove Overweight 312.33 375.00 375.00 Reiterates

Nomura Reduce 312.33 305.00 305.00 Reiterates